ArticleBlood advances2023

IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia.

Charlotte Syrykh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.